Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial
Ren, Zhenggang, Ducreux, Michel, Abou-Alfa, Ghassan K., Merle, Philippe, Fang, Weijia, Edeline, Julien, Li, Zhiwei, Wu, Lihua, Assenat, Eric, Hu, Sheng, Rimassa, Lorenza, Zhang, Tao, Blanc, Jean-Frédéric, Pan, Hongming, Ross, Paul, Yen, Chia-Jui, Tran, Albert, Shao, Guoliang, Bouattour, Mohamed, Chen, Yajin, Meyer, Tim, Hou, Jinlin, Tougeron, David, Bai, Yuxian, Hou, Ming-Mo, Meng, Zhiqiang, Wu, John, Li, Vincent, Chica-Duque, Sandra, Cheng, Ann-Lii
Published in Liver cancer (Basel ) (01.02.2023)
Published in Liver cancer (Basel ) (01.02.2023)
Get full text
Journal Article
362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced hepatocellular carcinoma
Merle, Philippe, Mata, Helena Verdaguer, Xie, Congying, Hubner, Richard, Liu, Yong, Margetts, Jane, Cheng, Ying, Chao, Yee, Fei, Cong, Ling, Chen, Huang, Ruiqi, Wu, Xikun, Shen, Zhirong, Li, Bai, Duque, Sandra Chica, Ren, Zhenggang
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
AdvanTIG-302: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus tislelizumab (TIS) versus pembrolizumab (PEM) in programmed death ligand-1 (PD-L1) selected, previously untreated, locally advanced, unresectable or metastatic non-small cell lung cancer (NSCLC)
Socinski, Mark A., Spira, Alexander I., Paz-Ares, Luis G., Reck, Martin, Lu, Shun, Nishio, Makoto, Li, Jiang, Zhou, Yunfei, Rhee, Joon Whan, Chica Duque, Sandra, Yu, Xinmin
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Clinical outcomes in patients (pts) with previously treated advanced hepatocellular carcinoma (HCC) experiencing hepatitis B virus (HBV) DNA increases during tislelizumab (TIS) treatment in RATIONALE-208
Cheng, Ann-Lii, Hou, Jinlin, Fang, Weijia, Li, Zhiwei, Hu, Sheng, Pan, Hongming, Chen, Yajin, Hsu, Chiun, Bai, Yuxian, Meng, Zhiqiang, Hou, Ming-Mo, Xie, Congying, Liu, Yong, Li, Vincent, Chica-Duque, Sandra, Wu, John, Ren, Zhenggang
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Clinical outcomes in patients (pts) with previously treated advanced hepatocellular carcinoma (HCC) experiencing hepatitis B virus (HBV) DNA increases during tislelizumab (TIS) treatment in RATIONALE-208
Cheng, Ann-Lii, Hou, Jinlin, Fang, Weijia, Li, Zhiwei, Hu, Sheng, Pan, Hongming, Chen, Yajin, Hsu, Chiun, Bai, Yuxian, Meng, Zhiqiang, Hou, Ming-Mo, Xie, Congying, Liu, Yong, Wu, John, Li, Bai, Chica-Duque, Sandra, Ren, Zhenggang
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Clinical outcomes associated with tislelizumab in patients (pts) with advanced hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (SOR) or lenvatinib (LEN) in RATIONALE-208
Edeline, Julien, Merle, Philippe, Fang, Weijia, Assenat, Eric, Pan, Hongming, Rimassa, Lorenza, Li, Zhiwei, Blanc, Jean-Frédéric, Yen, Chia-Jui, Ross, Paul J., Hu, Sheng, Zhang, Tao, Tran, Albert, Shao, Guoliang, Bouattour, Mohamed, Chen, Yajin, Wu, John, Li, Vincent, Chica-Duque, Sandra, Ren, Zhenggang
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Clinical outcomes associated with tislelizumab in patients (pts) with advanced hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (SOR) or lenvatinib (LEN) in RATIONALE-208
Edeline, Julien, Merle, Philippe, Fang, Weijia, Assenat, Eric, Pan, Hongming, Rimassa, Lorenza, Li, Zhiwei, Blanc, Jean-Frederic, Yen, Chia-Jui, Ross, Paul J., Hu, Sheng, Zhang, Tao, Tran, Albert, Shao, Guoliang, Bouattour, Mohamed, Chen, Yajin, Wu, John, Li, Bai, Chica-Duque, Sandra, Ren, Zhenggang
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article